Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health, Gut, vol.61, issue.2, pp.241-248, 2012. ,
DOI : 10.1136/gutjnl-2011-300049
URL : https://hal.archives-ouvertes.fr/hal-00683081
Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease, 2013. ,
How FDA Approves Drugs and Regulates Their Safety and Effectiveness, 2012. ,
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease, Gut, vol.38, issue.Suppl 8, pp.1288-94, 2013. ,
DOI : 10.2169/internalmedicine.38.102
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: A randomized controlled trial, Gastroenterology, vol.115, issue.6, pp.1340-1345, 1998. ,
DOI : 10.1016/S0016-5085(98)70011-3
Efficacy versus effectiveness trials, Current Opinion in Allergy and Clinical Immunology, vol.13, issue.1, pp.50-57, 2013. ,
DOI : 10.1097/ACI.0b013e32835ad059
Efficacy, effectiveness, and comparative effectiveness in liver disease, Hepatology, vol.361, issue.2, pp.403-410, 2010. ,
DOI : 10.1056/NEJMp0904133
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs, New England Journal of Medicine, vol.342, issue.25, pp.1887-92, 2000. ,
DOI : 10.1056/NEJM200006223422507
A Primer on Effectiveness and Efficacy Trials, Clinical and Translational Gastroenterology, vol.59, issue.1, p.45, 2014. ,
DOI : 10.1016/j.jclinepi.2006.01.011
Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population, Clinical Gastroenterology and Hepatology, vol.10, issue.9, pp.1002-1009, 2012. ,
DOI : 10.1016/j.cgh.2012.02.004
Treatment of irritable bowel syndrome: a review of randomised controlled trials, Gut, vol.48, issue.2, pp.272-82, 2001. ,
DOI : 10.1136/gut.48.2.272
Observationalversus experimental studies: What???s the evidence for a hierarchy?, NeuroRX, vol.137, issue.3, pp.341-348, 2004. ,
DOI : 10.7326/0003-4819-137-5_Part_1-200209030-00015
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report???Part II, Value in Health, vol.12, issue.8, pp.1053-61, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00601.x
Assessing risk of bias and confounding in observational studies of interventions or exposures: further development of the RTI Item Bank, ]: Agency for Healthcare Research and Quality, 2013. ,
Confounding and interaction, Handbook of Epidemiology, 2005. ,
GRACE principles: recognizing high-quality observational studies of comparative effectiveness, Am J Manag Care, vol.16, pp.467-71, 2010. ,
Selection bias in observational and experimental studies, Statistics in Medicine, vol.86, issue.5-7, pp.557-67, 1994. ,
DOI : 10.1161/01.STR.19.5.547
Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977???2009, The American Journal of Gastroenterology, vol.31, issue.4, pp.579-88, 1977. ,
DOI : 10.1016/j.dld.2008.09.010
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979???2011, Gut, vol.135, issue.(7 Suppl), pp.1607-1623, 1979. ,
DOI : 10.1053/j.gastro.2008.06.079
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire, J Rheumatol, vol.31, pp.1320-1326, 2004. ,
Serious Infections and Mortality in Association With Therapies for Crohn???s Disease: TREAT Registry, Clinical Gastroenterology and Hepatology, vol.4, issue.5, pp.621-651, 2006. ,
DOI : 10.1016/j.cgh.2006.03.002
Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report???Part I, Value in Health, vol.12, issue.8, pp.1044-1052, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00600.x
Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report???Part III, Value in Health, vol.12, issue.8, pp.1062-1073, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00602.x
On Guidelines for Comparative Effectiveness Research Using Nonrandomized Studies in Secondary Data Sources, Value in Health, vol.12, issue.8, p.1041, 2009. ,
DOI : 10.1111/j.1524-4733.2009.00607.x
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials, JAMA, vol.285, issue.15, pp.1987-91, 2001. ,
DOI : 10.1001/jama.285.15.1987
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, vol.335, issue.7624, pp.806-814, 2007. ,
DOI : 10.1136/bmj.39335.541782.AD
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease, Gastroenterology, vol.122, issue.2, pp.512-542, 2002. ,
DOI : 10.1053/gast.2002.31072
Definition and evaluation of mucosal healing in clinical practice, Digestive and Liver Disease, vol.45, issue.12, pp.969-77, 2013. ,
DOI : 10.1016/j.dld.2013.06.010
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal, Gastroenterology Research and Practice, vol.25, issue.10, p.832395, 2015. ,
DOI : 10.3748/wjg.v18.i36.5058
Statistical Analysis with Missing Data, 2002. ,
MATCHING AND UNRELATEDNESS, American Journal of Epidemiology, vol.100, issue.5, pp.347-356, 1974. ,
DOI : 10.1093/oxfordjournals.aje.a112043
Causal Diagrams for Epidemiologic Research, Epidemiology, vol.10, issue.1, pp.37-48, 1999. ,
DOI : 10.1097/00001648-199901000-00008
Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease, Gut, vol.62, issue.3, pp.387-94, 2013. ,
DOI : 10.1136/gutjnl-2011-301495
The central role of the propensity score in observational studies for causal effects, Biometrika, vol.70, issue.1, pp.41-55, 1983. ,
DOI : 10.1093/biomet/70.1.41
Variable Selection for Propensity Score Models, American Journal of Epidemiology, vol.163, issue.12, pp.1149-56, 2006. ,
DOI : 10.1093/aje/kwj149
Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.19, issue.3, pp.239-286, 2012. ,
DOI : 10.1002/pds.1926
Estimating Causal Effects from Large Data Sets Using Propensity Scores, Annals of Internal Medicine, vol.127, issue.8_Part_2, pp.757-63, 1997. ,
DOI : 10.7326/0003-4819-127-8_Part_2-199710151-00064
Multiple Imputation for Nonresponse in Surveys, 1987. ,
DOI : 10.1002/9780470316696
Effectiveness of Anti-TNF?? for Crohn Disease: Research in a Pediatric Learning Health System, PEDIATRICS, vol.134, issue.1, pp.37-44, 2014. ,
DOI : 10.1542/peds.2013-4103
Methods of Multivariate Analysis, 2012. ,
Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates, Journal of Clinical Epidemiology, vol.48, issue.12, pp.1503-1513, 1995. ,
DOI : 10.1016/0895-4356(95)00048-8
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Statistics in Medicine, vol.17, issue.19, pp.2265-81, 1998. ,
DOI : 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
Modeling Survival Data: Extending the Cox Model, 2000. ,
DOI : 10.1007/978-1-4757-3294-8
Natural History of Pediatric Crohn's Disease: A Population-Based Cohort Study, Gastroenterology, vol.135, issue.4, pp.1106-1119, 2008. ,
DOI : 10.1053/j.gastro.2008.06.079
On Estimation and Tests of Time-Varying Effects in the Proportional Hazards Model, Scandinavian Journal of Statistics, vol.88, issue.1, pp.51-62, 2004. ,
DOI : 10.1023/A:1015849821021
The Effectiveness of Adjustment by Subclassification in Removing Bias in Observational Studies, Biometrics, vol.24, issue.2, pp.295-313, 1968. ,
DOI : 10.2307/2528036
Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials, JAMA: The Journal of the American Medical Association, vol.266, issue.1, pp.93-101, 1991. ,
DOI : 10.1001/jama.1991.03470010097038
How to work with a subgroup analysis, Can J Surg, vol.52, pp.515-537, 2009. ,
Subgroup analyses in randomized trials: risks of subgroup-specific analyses;, Journal of Clinical Epidemiology, vol.57, issue.3, pp.229-265, 2004. ,
DOI : 10.1016/j.jclinepi.2003.08.009
Multiple analyses in clinical trials: sound science or data dredging?, Med J Aust, vol.181, pp.452-456, 2004. ,
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, The Lancet, vol.374, issue.9701, pp.1617-1642, 2009. ,
DOI : 10.1016/S0140-6736(09)61302-7
URL : https://hal.archives-ouvertes.fr/hal-00466312
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study, Gut, vol.142, issue.Suppl 1, pp.433-474, 2014. ,
DOI : 10.1016/S0016-5085(12)63046-7